6/10
08:04 am
anab
AnaptysBio (ANAB) had its "buy" rating reaffirmed by HC Wainwright. They now have a $95.00 price target on the stock.
Low
Report
AnaptysBio (ANAB) had its "buy" rating reaffirmed by HC Wainwright. They now have a $95.00 price target on the stock.
5/13
10:31 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
5/13
10:08 am
anab
Rating for ANAB
Medium
Report
Rating for ANAB
5/13
10:08 am
anab
Rating for ANAB
Medium
Report
Rating for ANAB
5/13
09:00 am
anab
AnaptysBio (ANAB) had its "buy" rating reaffirmed by UBS Group AG.
Medium
Report
AnaptysBio (ANAB) had its "buy" rating reaffirmed by UBS Group AG.
5/13
06:00 am
anab
AnaptysBio (ANAB) had its "overweight" rating reaffirmed by Barclays PLC.
Medium
Report
AnaptysBio (ANAB) had its "overweight" rating reaffirmed by Barclays PLC.
4/28
08:50 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
4/24
07:32 am
anab
First Tracks Biotherapeutics initiated with an Outperform at Leerink
High
Report
First Tracks Biotherapeutics initiated with an Outperform at Leerink
4/22
09:11 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
4/22
09:11 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
4/21
03:35 pm
anab
Rating for ANAB
Low
Report
Rating for ANAB